Alex Azar Confirmed as New HHS Secretary

Jan. 29, 2018
By Adam Lotspike

On Jan. 24, the United States Senate confirmed Alex Azar as the next secretary of the U.S. Department of Health and Human Services (HHS) by a vote of 55 to 43. Our statement applauding his confirmation is available here.

HHS plays a critical role in the life sciences innovation ecosystem through its extensive programs and agencies. These include agencies which regulate medical technology, biopharmaceutical, and public health research in California and beyond, such as the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC); the world’s pre-eminent publicly funded medical research institution, the National Institutes of Health (NIH); and the Centers for Medicare & Medicaid Services (CMS), which oversees the reimbursement of innovative products through its health coverage and payment programs.

CLSA is eager to work with Secretary Azar and HHS agencies to ensure transparent and timely product review and reimbursement processes, maintain sustained public investment in basic and translational research. We look forward to being a valuable partner in the current national debate on how to transition our healthcare system to one that is patient-centric, rewards value and sustained innovation, and promotes competition and choice.

To learn more about Secretary Azar, click here. Questions? Please contact Jenny Carey, CLSA’s Vice President of Federal Government Relations & Alliance Development (